| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000236869.1 |
Methotrexate |
Breast invasive carcinoma |
0.013172368 |
Resistant |
| ENSG00000236869.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.036212319 |
Resistant |
| ENSG00000236869.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.002199128 |
Resistant |
| ENSG00000236869.1 |
Methotrexate |
Esophageal cancer |
0.012546943 |
Sensitive |
